Search Results 521-530 of 21250 for anti-TNF drugs

1. Sulfonamide (Oral Route) Proper Use - Mayo Clinic

   If you need help in planning the best times to take your medicine, check with your health care professional. Dosing. The dose medicines in this class will be ...

2. Triamcinolone (Topical Application Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aristocort A; Cinolar; Dermasorb TA Complete Kit; Kenalog ...

3. Salicylate (Oral Route, Rectal Route) Before Using - Mayo Clinic

   Caffeine passes into the breast milk in small amounts. Drug Interactions. Although certain medicines should not be used together at all, in other cases two ...

4. Lithium (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Artemether And Lumefantrine (Oral Route) Description and Brand Names - Mayo Clinic

   Artemether and lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by ...

6. Some pain medicines may increase heart attack risk after surgery - Mayo Clinic News Network

   In a McGill University study published recently in the British Medical Journal, researchers found that post-surgery use of nonsteroidal anti-inflammatory drugs ...

7. Mayo Clinic Health Letter: Highlights from the March 2015 Issue

   Anti-seizure medications can help reduce this activity and decrease pain levels. Nonmedication strategies ― Using drugs to manage chronic pain usually works ...

8. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

9. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

10. Secukinumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Secukinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...